Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) EBITDA Margin (2020 - 2025)

iSpecimen has reported EBITDA Margin over the past 6 years, most recently at 9662.19% for Q4 2025.

  • For Q4 2025, EBITDA Margin fell 925238.0% year-over-year to 9662.19%; the TTM value through Dec 2025 reached 543.68%, down 40916.0%, while the annual FY2025 figure was 543.68%, 40916.0% down from the prior year.
  • EBITDA Margin for Q4 2025 was 9662.19% at iSpecimen, down from 2608.68% in the prior quarter.
  • Over five years, EBITDA Margin peaked at 31.81% in Q1 2021 and troughed at 9662.19% in Q4 2025.
  • A 5-year average of 717.38% and a median of 102.08% in 2022 define the central range for EBITDA Margin.
  • Biggest five-year swings in EBITDA Margin: soared 14552bps in 2024 and later crashed -925238bps in 2025.
  • Year by year, EBITDA Margin stood at 78.26% in 2021, then increased by 8bps to 72.31% in 2022, then crashed by -54bps to 111.49% in 2023, then crashed by -268bps to 409.81% in 2024, then tumbled by -2258bps to 9662.19% in 2025.
  • Business Quant data shows EBITDA Margin for ISPC at 9662.19% in Q4 2025, 2608.68% in Q3 2025, and 146.85% in Q2 2025.